Browsing: News

As myopia rates soar, especially across Asia-Pacific, the 4th APMMS event spotlighted advanced solutions like CooperVision’s MiSight® 1 day lenses and multi-stakeholder collaborations. Experts and attendees emphasized the need for early intervention, reshaping myopia management to prioritise disease prevention.

HSA has banned “Q-nic Care Whitening Underarm Cream,” citing dangerous mercury and steroid levels. The authority urges users to stop immediately and warns about potential skin and health risks. Consumers are advised to purchase health products only from reputable sources to avoid unsafe ingredients.

His Majesty Sultan Ibrahim, alongside Health Minister Dr. Dzulkefly Ahmad, opened the MIH Megatrends 2024 in Kuala Lumpur. The event aims to drive forward-thinking solutions in healthcare and foster collaboration among Malaysia’s healthcare, business, and government sectors.

Malaysia’s MIH Megatrends 2024 gathers healthcare leaders, innovators, and policymakers worldwide to explore advancements in AI, robotics, and telemedicine. This three-day event, featuring public health screenings, family zones, and digital innovations, sets the stage for Malaysia’s role in ASEAN healthcare.

Tun Dr Mahathir, Malaysia’s former prime minister, has been hospitalised due to a lung infection, which poses serious risks given his heart condition and history of bypass surgeries. He is receiving in-patient care at the National Heart Institute (IJN) to manage both his lung and heart health.

Our highly anticipated inaugural Connecting Care with Clicks 2024 event was an incredible success! Held at The Westin Kuala Lumpur, the event attracted a diverse audience of healthcare professionals and healthcare industry leaders, all eager to shape the healthcare landscape together for the better.

A Lien Foundation survey revealed that while 70% of Singaporeans are aware of palliative care, 39% know little about it, with many mistakenly associating it solely with end-of-life care. These misconceptions hinder early adoption, limiting the potential benefits for patients throughout serious illnesses.